Aurobindo acquires 7 oncology drugs from spectrum for $300 million
Hyderabad: Aurobindo Pharma on Thursday said it has acquired seven marketed oncology injectable products from Spectrum Pharmaceuticals Inc for about $300 million, which includes an upfront cash payment of up…